Cabozantinib in combination with immune checkpoint inhibitors for renal cell carcinoma: a systematic review and meta-analysis

• Autori principali: Jingyang Su (Autore), Jialin Zhang (Autore), Yuqian Wu (Autore), Cui Ni (Autore), Yueyue Ding (Autore), Zelin Cai (Autore), Ming Xu (Autore), Mingyang Lai (Autore), Jue Wang (Autore), Shengyou Lin (Autore), Jinhua Lu (Autore)
• Natura: Libro
• Pubblicazione: Frontiers Media S.A., 2024-04-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

ContextCabozantinib combined with immune checkpoint inhibitors (ICIs) has brought a new therapeutic effect for the medical treatment of renal cell carcinoma (RCC).ObjectivesWe performed a meta-analysis of randomized controlled trials and single-arm trials to evaluate the efficacy and safety of caboz...